Page 4 - Strides Pharma
Strides Pharma Q2 net loss at Rs 87 million on poor operating income
Consolidated revenue also saw a marginal degrowth of 4.6 per cent at Rs 7.3 billion
 "Strides Pharma Q2 net loss at Rs 87 million on poor operating income")
Updated On : 01 Nov 2018 | 12:55 AM IST
Strides Pharma to get $20 mn funding for consumer healthcare business
The stocks of Strides Pharma Science were trading flat at Rs 426.35 per scrip on the BSE, up 3.05 per cent over its previous close
 "Strides Pharma to get $20 mn funding for consumer healthcare business")
Updated On : 31 Oct 2018 | 3:38 PM IST
Strides Pharma receives USFDA approval for antiepileptic drug Gabapentin
The product will be marketed by Strides Pharma Inc in the US market
 "Strides Pharma receives USFDA approval for antiepileptic drug Gabapentin")
Updated On : 20 Oct 2018 | 8:24 PM IST
Strides Pharma gets US FDA approval for hypokalemia treatment drug
The tablets, used to treat hypokalemia, will be available in 600 mg and 750 mg dosage
 "Strides Pharma gets US FDA approval for hypokalemia treatment drug")
Updated On : 05 Sep 2018 | 6:36 PM IST
